@TumorBoardTues 1/17 #TumorBoardTuesday #BreastCancer #OncTwitter 56 yo 👩🏽 postmenopausal 🚫comorbidities De novo MBC to 🦴 ER 95% PR 88%, HER2 1+

@TumorBoardTues 1/17 #TumorBoardTuesday #BreastCancer #OncTwitter 56 yo 👩🏽 postmenopausal 🚫comorbidities De novo MBC to 🦴 ER 95% PR 88%, HER2 1+